GLP-1 and macular degeneration link shifts after health risks are accounted for

Analysis of more than 300 million patient records suggests the apparent association between GLP-1 medicines and age-related macular degeneration may largely reflect underlying cardiometabolic conditions. At the annual meeting of the American Academy of Ophthalmology in New Orleans, researchers presented…













